IL135911A0 - Dna 19355 polypeptide, a tumor necrosis factor homolog - Google Patents

Dna 19355 polypeptide, a tumor necrosis factor homolog

Info

Publication number
IL135911A0
IL135911A0 IL13591198A IL13591198A IL135911A0 IL 135911 A0 IL135911 A0 IL 135911A0 IL 13591198 A IL13591198 A IL 13591198A IL 13591198 A IL13591198 A IL 13591198A IL 135911 A0 IL135911 A0 IL 135911A0
Authority
IL
Israel
Prior art keywords
polypeptide
necrosis factor
tumor necrosis
dna19355
dna
Prior art date
Application number
IL13591198A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL135911A0 publication Critical patent/IL135911A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13591198A 1997-11-18 1998-11-18 Dna 19355 polypeptide, a tumor necrosis factor homolog IL135911A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6563597P 1997-11-18 1997-11-18
US6966197P 1997-12-12 1997-12-12
PCT/US1998/024621 WO1999025834A1 (fr) 1997-11-18 1998-11-18 Polypeptide adn19355, homologue du facteur de necrose des tumeurs

Publications (1)

Publication Number Publication Date
IL135911A0 true IL135911A0 (en) 2001-05-20

Family

ID=26745805

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13591198A IL135911A0 (en) 1997-11-18 1998-11-18 Dna 19355 polypeptide, a tumor necrosis factor homolog

Country Status (12)

Country Link
US (4) US20020146389A1 (fr)
EP (1) EP1032672B1 (fr)
JP (2) JP4485049B2 (fr)
AT (1) ATE419357T1 (fr)
AU (1) AU760010B2 (fr)
CA (1) CA2308365A1 (fr)
DE (1) DE69840413D1 (fr)
DK (1) DK1032672T3 (fr)
ES (1) ES2320285T3 (fr)
IL (1) IL135911A0 (fr)
PT (1) PT1032672E (fr)
WO (1) WO1999025834A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406867B1 (en) 1996-08-16 2002-06-18 Human Genome Sciences, Inc. Antibody to human endokine alpha and methods of use
WO2001040464A1 (fr) * 1999-11-30 2001-06-07 Genentech, Inc. Kinase 3 associee au recepteur de l'interleukine 1 (irak3) et son utilisation pour stimuler ou inhiber l'angiogenese et la cardiovascularisation
ES2307515T3 (es) * 1999-06-02 2008-12-01 Genentech Inc Activacion o inhibicion de la angiogenesis y la cardiovascularizacion.
WO2001003720A2 (fr) * 1999-07-12 2001-01-18 Genentech, Inc. Stimulation ou inhibition de l'angiogenese et de la cardiovascularisation avec des homologues de ligands et de recepteurs du facteur de necrose tumorale
AU6391000A (en) * 1999-07-28 2001-02-19 Genentech Inc. Method of preventing the injury or death of retinal cells and treating ocular diseases
DE10045591A1 (de) * 2000-09-15 2002-04-04 Klaus Pfizenmaier Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine)
WO2003006058A1 (fr) * 2001-07-12 2003-01-23 Wyeth Marqueurs differentiels cd25+ et leurs utilisations
AU2002366433A1 (en) * 2001-08-16 2003-09-09 Human Genome Sciences, Inc. Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
CN1658863A (zh) * 2002-04-08 2005-08-24 武田药品工业株式会社 重症脓毒病预防治疗药物
WO2004107618A2 (fr) * 2003-05-23 2004-12-09 Wyeth Ligand du gitr et molecules et anticorps lies au ligand du gitr et leurs utilisations
EP1660126A1 (fr) * 2003-07-11 2006-05-31 Schering Corporation Agonistes ou antagonistes du recepteur du facteur de necrose tumorale induit par les glucocorticoides (gitr) ou de son ligand utilises dans le traitement des troubles immuns, des infections et du cancer
EP1692318A4 (fr) * 2003-12-02 2008-04-02 Genzyme Corp Compositions et methodes pour le diagnostic et le traitement du cancer du poumon
US20070065889A1 (en) * 2004-12-02 2007-03-22 Roberts Bruce L Compositions and methods to diagnose and treat lung cancer
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
BR112016028378A2 (pt) 2014-06-06 2017-10-24 Bristol Myers Squibb Co anticorpos contra o receptor do fator de necrose tumoral induzido por glicocorticoide (gitr) e usos dos mesmos
MA41460A (fr) 2015-02-03 2017-12-12 Oncomed Pharm Inc Agents de liaison à la tnfrsf et leurs utilisations
WO2016196792A1 (fr) 2015-06-03 2016-12-08 Bristol-Myers Squibb Company Anticorps anti-gitr pour le diagnostic du cancer
AU2016356780A1 (en) 2015-11-19 2018-06-28 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
AU2017278193B9 (en) 2016-06-10 2024-02-01 Regeneron Pharmaceuticals, Inc. Anti-GITR antibodies and uses thereof
KR20200006115A (ko) 2017-05-16 2020-01-17 브리스톨-마이어스 스큅 컴퍼니 항-gitr 효능제 항체에 의한 암의 치료
US11787867B2 (en) 2020-03-06 2023-10-17 Regeneron Pharmaceuticals, Inc. Anti-GITR antibodies and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
KR100510234B1 (ko) * 1995-06-29 2005-11-25 임뮤넥스 코포레이션 세포소멸을 유도하는 시토킨
ATE412740T1 (de) * 1996-08-16 2008-11-15 Human Genome Sciences Inc Menschliches alpha-endokin
US6406867B1 (en) * 1996-08-16 2002-06-18 Human Genome Sciences, Inc. Antibody to human endokine alpha and methods of use
US5998171A (en) * 1996-08-16 1999-12-07 Human Genome Sciences, Inc. Polynucleotides encoding human endokine alpha

Also Published As

Publication number Publication date
AU760010B2 (en) 2003-05-08
US20040234498A1 (en) 2004-11-25
US20070072263A1 (en) 2007-03-29
PT1032672E (pt) 2009-04-02
DK1032672T3 (da) 2009-04-27
DE69840413D1 (de) 2009-02-12
US20060216270A1 (en) 2006-09-28
CA2308365A1 (fr) 1999-05-27
JP4485049B2 (ja) 2010-06-16
JP2010088448A (ja) 2010-04-22
EP1032672B1 (fr) 2008-12-31
WO1999025834A1 (fr) 1999-05-27
AU1418099A (en) 1999-06-07
JP2001523459A (ja) 2001-11-27
EP1032672A1 (fr) 2000-09-06
ATE419357T1 (de) 2009-01-15
ES2320285T3 (es) 2009-05-20
US20020146389A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
IL135911A0 (en) Dna 19355 polypeptide, a tumor necrosis factor homolog
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
TW428026B (en) Bifunctional protein, preparation and use
MX9603532A (es) Sistema de suministro de acido nucleico, metodo de sintesis y sus usos.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE69535719D1 (de) Fas-antigenbindender ligand
HK1034287A1 (en) Recombinational cloning using nucleic acids havingrecombination sites
DE69532532T8 (de) Chimerische papillomavirus-ahnliche partikel
IE812224L (en) Interferon
IL125168A0 (en) Apo - 2 ligand
EP0237966A3 (fr) Facteur humain basique de croissance de fibroblaste
WO1998021343A8 (fr) Genes codant des proteines de telomerase
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
IL135051A0 (en) Apo-3 ligand polypeptide
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
EP0336383A3 (fr) Lymphotoxine recombinante humaine
ATE236983T1 (de) Durch zelldichte stimulierte protein-tyrosin- phosphatasen
ZA95968B (en) Interferon alpha/beta binding protein its preparation and use
DE69828902D1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren
PT1241179E (pt) Proteína humana possuindo actividade antiproliferativa in vitro
MX9802005A (es) Moleculas de adn circular con origen de replicacion condicional, su proceso de preparacion y su utilizacion en terapia genica.
WO2002006340A3 (fr) Proteine tetraspan et ses utilisations
EP2033970A3 (fr) Gènes inductibles WNT-1